Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Expected to Be in 2029?
In recent times, the market size for robot-assisted percutaneous coronary intervention (PCI) has seen significant growth. The market, which stands at $19.59 billion in 2024, is projected to increase to a hefty $27.56 billion in 2025, representing a compound annual growth rate (CAGR) of 40.7%. Factors contributing to this historical growth include an increase in clinical trials validating robotic percutaneous coronary intervention, higher success rates of these procedures compared to traditional interventions, a surge in training programs for doctors on robotic systems, a rising patient preference for advanced treatment methods, and the increasing inclusion of reimbursement policies in more developed regions.
The market for robot-assisted percutaneous coronary intervention (PCI) is forecasted to experience significant growth in the coming years, ballooning to a value of $106.86 billion by 2029, with a compound annual growth rate (CAGR) of 40.3%. This projected growth during the forecast period is due to several factors, including the increasing use of 5G technology and remote operations capabilities in real-time, the expansion of robotic PCI systems in ambulatory surgical centers, the focus on minimizing the hospital stay following PCI, a heightened interest from venture capitalists in robotic cardiology startups, and the elevated use of machine learning in procedural planning and guidance. Future trends anticipated in the forecast period include the progression of cloud-based robotic PCI platforms for immediate data sharing, improved cybersecurity measures for the safeguarding of robot-assisted procedural data, the creation of robotic systems designed specifically for outpatient cardiac care, advancements in AI-driven robotic learning using procedural datasets, and the development of miniaturized robotic instruments for highly accurate coronary navigation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp
What Are The Contributors To Demand In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
The surge in cardiovascular ailments is likely to stimulate the expansion of the market for robot-assisted percutaneous coronary intervention (PCI). These diseases encompass various disorders afflicting the heart and blood vessels such as coronary artery disease, stroke, and heart attacks. Sedentary lifestyles are causing an increase in these diseases, leading to issues like obesity, hypertension and poor cardiac health. The robot-assisted percutaneous coronary intervention (PCI) addresses these ailments by adeptly unblocking or dilating constricted coronary arteries, thereby restoring heart’s blood supply while minimizing procedure-associated risks and exposure to radiation, thus improving patient outcomes. As an illustration, data from the American Heart Association, a nonprofit based out of the US, points out that there were 131,454 deaths primarily due to high blood pressure in January 2024, which marks an upturn from the 124,508 deaths recorded in 2021. Consequently, the escalating incidence of cardiovascular diseases is propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.
What Segmentation Categories Are Included In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Analysis?
The robot-assisted percutaneous coronary intervention (PCI) market covered in this report is segmented
1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles
2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy
3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems
2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters
3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels
What Upcoming Trends Are Expected To Impact The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Globally?
Leading businesses in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on the creation of state-of-the-art robotic cardiology systems, aimed at enhancing patient safety and making complicated coronary procedures more manageable. Robotic cardiology platforms, equipped with high-tech features, assist healthcare professionals in executing precise, controlled coronary interventions. Such platforms help enhance precision, minimize human errors, and reduce radiation exposure to both patients and the medical workforce. For instance, in May 2023, Robocath SAS, a French company known for its expertise in robotic vascular intervention solutions, unveiled the R-One+. This groundbreaking robotic technology empowers interventional cardiologists to carry out coronary angioplasties (percutaneous coronary intervention, or PCI) by controlling the devices via a centralized command unit situated either in the cath lab or control room. The R-One+ boosts the accuracy of device manoeuvres, enhances safety through reduced radiation exposure for patients and medical specialists, and offers more conducive working conditions for operators. Debuted at the EuroPCR conference in Paris, the revolutionary platform showcased never-before-seen capabilities that simplify PCI procedures, and safeguard the cardiac team from injuries due to radiation. This technological advancement exhibits Robocath’s dedication to enhance the treatment of cardiovascular illnesses via intelligent robotic backing.
Who Are The Top-Ranked Companies In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Today?
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Medical Microinstruments, Quantum Surgical, Stereotaxis Inc., THINK Surgical Inc., Perfint Healthcare, Robocath Inc., SS Innovations, Auris Health, EP Solutions SA, NDR Medical Technology, Meril Life Sciences Pvt. Ltd.
Get The Full Report Here:
How Is Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (PCI) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model